Literature DB >> 15866318

Cytokines in multiple sclerosis: from bench to bedside.

Jaime Imitola1, Tanuja Chitnis, Samia J Khoury.   

Abstract

Cytokines play an important role in the pathogenesis of inflammatory diseases including multiple sclerosis (MS). Experimental models have played a critical role in unraveling the roles of individual cytokines in this disease; however, these studies occasionally yield conflicting results, highlighting the complex role cytokines play in the disease process. Efforts to modulate cytokine function in MS have shown that effective treatments alter cytokine expression in the central nervous system (CNS) and in activated mononuclear cells, indicating that they are important therapeutic targets. In this review, we will summarize the current knowledge on the role of cytokine pathways in MS and what we learned from investigation of its animal model: experimental autoimmune encephalomyelitis (EAE).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866318     DOI: 10.1016/j.pharmthera.2004.11.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  60 in total

1.  Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways.

Authors:  Wensheng Lin; Yifeng Lin
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

2.  The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.

Authors:  Wensheng Lin; Samantha L Bailey; Hanson Ho; Heather P Harding; David Ron; Stephen D Miller; Brian Popko
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

3.  Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.

Authors:  Claudia Mara Ribeiro; Sayonara Rangel Oliveira; Daniela Frizon Alfieri; Tamires Flauzino; Damacio Ramón Kaimen-Maciel; Andréa Name Colado Simão; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Inflamm Res       Date:  2019-09-26       Impact factor: 4.575

Review 4.  Glial connexins and gap junctions in CNS inflammation and disease.

Authors:  Tammy Kielian
Journal:  J Neurochem       Date:  2008-04-10       Impact factor: 5.372

5.  Stimulation of adult oligodendrogenesis by myelin-specific T cells.

Authors:  Helle Hvilsted Nielsen; Henrik Toft-Hansen; Kate Lykke Lambertsen; Trevor Owens; Bente Finsen
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

6.  Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis.

Authors:  Uğur Kulu; Bedile İrem Tiftikcioğlu; Yaşar Zorlu; Mustafa Çetiner; Ufuk Şener; Gamze Tuna; Güldal Kirkali
Journal:  Noro Psikiyatr Ars       Date:  2016-03-28       Impact factor: 1.339

7.  Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma.

Authors:  Wensheng Lin; Phillip E Kunkler; Heather P Harding; David Ron; Richard P Kraig; Brian Popko
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

8.  Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis.

Authors:  Kaiyong Yang; Jose L Vega; Muhamed Hadzipasic; Jean Pierre Schatzmann Peron; Bing Zhu; Yijun Carrier; Sharmila Masli; Luiz Vicente Rizzo; Howard L Weiner
Journal:  J Autoimmun       Date:  2009-02-01       Impact factor: 7.094

9.  Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous system.

Authors:  C E Thomson; M McCulloch; A Sorenson; S C Barnett; B V Seed; I R Griffiths; M McLaughlin
Journal:  Eur J Neurosci       Date:  2008-09-10       Impact factor: 3.386

Review 10.  Endoplasmic reticulum stress in disorders of myelinating cells.

Authors:  Wensheng Lin; Brian Popko
Journal:  Nat Neurosci       Date:  2009-03-15       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.